Proteinases and myocardial extracellular matrix turnover

Area of Science:

• Cardiovascular Biology
• Extracellular Matrix Research
• Pathological Remodeling

Background:

• Myocardial infarction causes adverse tissue remodeling, including ventricular thinning and dilation, leading to heart failure.
• The extracellular matrix (ECM) is crucial for maintaining myocardial structural integrity and cardiac cell alignment.
• An imbalance in proteinase/antiproteinase activity disrupts ECM stability, contributing to pathological remodeling post-myocardial infarction.

Purpose of the Study:

• To review the role of matrix metalloproteinases (MMPs), their inhibitors, and activators in cardiac remodeling.
• To provide new insights into the mechanisms underlying ECM turnover and adverse remodeling following myocardial infarction.
• To highlight the potential of targeting proteinase-antiproteinase systems for treating ischemic heart disease.

Main Methods:

• Literature review focusing on matrix metalloproteinases and their inhibitors/activators.
• Analysis of existing research on extracellular matrix remodeling in the context of myocardial infarction.
• Synthesis of information on proteinase and antiproteinase balance in cardiac tissue.

Main Results:

• Myocardial infarction leads to an imbalance in proteinase/antiproteinase activities.
• This imbalance causes alterations in ECM stability and integrity, resulting in adverse tissue remodeling.
• Activated matrix proteinases and antiproteinases play a significant role in the remodeling process.

Conclusions:

• Understanding the role of activated matrix proteinases and antiproteinases is crucial for comprehending cardiac remodeling.
• This knowledge can inform the development of novel pharmacological strategies for ischemic heart disease and heart failure.
• Targeting ECM turnover mechanisms offers potential therapeutic avenues for cardiovascular diseases.